# DAGLB

## Overview
DAGLB is a gene that encodes the enzyme diacylglycerol lipase beta, a crucial component in lipid metabolism and cell signaling. This enzyme is primarily responsible for the biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG) through the hydrolysis of diacylglycerol (DAG) at the sn-1 position. Diacylglycerol lipase beta is predominantly localized in the endoplasmic reticulum and plasma membrane, where it plays a significant role in modulating neurotransmitter release and neuronal activity, particularly in the central nervous system (Shin2019Lipid-metabolizing; Davies2020AP4). The enzyme is also involved in the regulation of inflammatory responses, influencing the production of prostaglandins and cytokines. Furthermore, DAGLB interacts with the AP-4 vesicle pathway, which is essential for its proper localization and function in neurons, highlighting its importance in neuronal development and function (Davies2022AP4mediated).

## Function
The human gene DAGLB encodes the enzyme diacylglycerol lipase beta, which is crucial for the production of the endocannabinoid 2-arachidonoylglycerol (2-AG). This enzyme catalyzes the hydrolysis of diacylglycerol (DAG) at the sn-1 position to produce 2-AG, a key signaling lipid in the central nervous system (Davies2020AP4). DAGLB is predominantly active in the endoplasmic reticulum and plasma membrane of cells, where it plays a significant role in lipid metabolism and cell signaling pathways (Shin2019Lipid-metabolizing).

In healthy human cells, particularly in nigral dopaminergic neurons, DAGLB is the main 2-AG synthase. The 2-AG produced by DAGLB modulates dopamine release and neuron activity, which are essential for motor functions and learning processes (Liu2021Deficiency). DAGLB-mediated 2-AG biosynthesis acts on presynaptic CB1 receptors to suppress inhibitory neurotransmitter release, enhancing dopamine release and neuron firing, which is crucial for motor performance and learning (Liu2021Deficiency).

DAGLB is also involved in the regulation of inflammatory responses. In macrophages and microglia, its activity affects the levels of 2-AG and arachidonic acid, influencing the production of prostaglandins and proinflammatory cytokines (Shin2019Lipid-metabolizing).

## Clinical Significance
Mutations or alterations in the DAGLB gene, which encodes diacylglycerol lipase beta, have been implicated in several neurological conditions. In the context of AP-4 deficiency syndrome, particularly in patients with AP4B1 deficiency (SPG47), DAGLB is mislocalized in neurons, leading to its accumulation at the trans-Golgi network instead of being properly transported to axons. This mislocalization is believed to contribute to neurodevelopmental issues associated with the syndrome, such as reduced axonal growth and branching, and axonal swellings. These defects are thought to arise from disrupted endocannabinoid signaling, as DAGLB is crucial for the production of the endocannabinoid 2-arachidonoylglycerol (2-AG), which is necessary for axonal growth and guidance (Davies2020AP4).

The spatial dysregulation of 2-AG synthesis due to DAGLB mislocalization may lead to developmental defects in axon formation, potentially explaining the neurological symptoms observed in AP-4 deficiency syndrome. This includes global developmental delay, intellectual disability, seizures, and progressive spasticity (Davies2020AP4). The study suggests that pharmacological interventions to increase 2-AG levels might correct axonal defects in AP-4 deficient cells, offering potential treatment strategies (Davies2020AP4).

## Interactions
DAGLB (diacylglycerol lipase beta) is involved in several protein interactions, primarily through its role in the AP-4 vesicle pathway. It is identified as a cargo protein of the AP-4 complex, which is crucial for its proper localization and function in neurons. DAGLB colocalizes with AP-4 vesicle proteins such as ATG9A, SERINC1, and SERINC3, indicating a physical interaction with these proteins within AP-4-derived vesicles (Davies2022AP4mediated). The interaction with the AP-4 complex is essential for the transport of DAGLB to axons, and its mislocalization in AP-4-deficient cells leads to impaired endocannabinoid signaling (Davies2022AP4mediated; Davies2020AP4).

DAGLB is also involved in interactions with the kinesin-1 molecular motor via the accessory protein RUSC2, which facilitates its transport along microtubules (Davies2022AP4mediated). This interaction is dependent on the presence of AP-4, as demonstrated by the loss of colocalization in AP-4 knockout cells (Davies2020AP4). These interactions highlight DAGLB's role in the spatial regulation of endocannabinoid production and its importance in neuronal development.


## References


[1. (Shin2019Lipid-metabolizing) Myungsun Shin, Timothy B. Ware, Hyeon-Cheol Lee, and Ku-Lung Hsu. Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1864(6):907–921, June 2019. URL: http://dx.doi.org/10.1016/j.bbalip.2018.08.007, doi:10.1016/j.bbalip.2018.08.007. This article has 12 citations.](https://doi.org/10.1016/j.bbalip.2018.08.007)

[2. (Davies2022AP4mediated) Alexandra K. Davies, Julian E. Alecu, Marvin Ziegler, Catherine G. Vasilopoulou, Fabrizio Merciai, Hellen Jumo, Wardiya Afshar-Saber, Mustafa Sahin, Darius Ebrahimi-Fakhari, and Georg H. H. Borner. Ap-4-mediated axonal transport controls endocannabinoid production in neurons. Nature Communications, February 2022. URL: http://dx.doi.org/10.1038/s41467-022-28609-w, doi:10.1038/s41467-022-28609-w. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-28609-w)

3. (Liu2021Deficiency) Deficiency in endocannabinoid synthase DAGLB contributes to Parkinson’s disease and dopaminergic neuron dysfunction. This article has 2 citations.

4. (Davies2020AP4) AP-4 mediates vesicular transport of the 2-AG endocannabinoid producing enzyme DAGLB. This article has 2 citations.